Treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin’s lymphoma (gray zone lymphoma) in children and young adults: a case series
| Autor: | E. V. Volchkov, M. A. Senchenko, D. S. Abramov, E. R. Biyachuev, O. N. Prudnikova, D. M. Konovalov, N. V. Myakova |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Pediatric Hematology/Oncology and Immunopathology. 21:94-102 |
| ISSN: | 2414-9314 1726-1708 |
| DOI: | 10.24287/1726-1708-2022-21-1-94-102 |
| Popis: | B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma (DLBCL) and classical Hodgkin’s lymphoma (cHL) is a rare malignant disease that develops from mature B cells. This disease was first recognized as a distinct entity in 2008. It is most common in the 20 to 40 age group and rare in children. Currently, there are no clear criteria for diagnosis and standard therapy for such patients. According to the literature, it is possible to use treatment regimens applied for both aggressive B-cell lymphomas and Hodgkin's lymphoma. The addition of anti-CD20/CD30 targeted agent to standard therapy may be effective, given the expression of these markers by tumor cells. In this article, we present the clinical and morphological characteristics of patients with unclassifiable B-cell lymphoma with features intermediate between DLBCL and cHL, diagnosed at our center, including 4 patients at the onset of the disease in childhood. Patients and/or their legal representatives have consented to the use of information, including photographs, in scientific research and publications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|